Exela provides global pharmaceutical innovators with a single regional partner to license and commercialize innovative therapies, differentiated products, and niche and complex generics across Southeast Asia — simplifying deal structures, accelerating execution, and reducing fragmentation across markets
In-Licensing
Bringing innovative products to Southeast Asia
Exela seeks innovative and differentiated pharmaceutical products, as well as niche and complex generics, from global partners for licensing and commercialization across Southeast Asia.
Out-Licensing
Expanding selected assets into new markets
Exela offers selected products and assets under its commercial rights for licensing to qualified partners seeking to commercialize them in markets outside Exela’s direct commercial footprint.
Distribution Partnerships
Exela partners with pharmaceutical manufacturers to bring niche, complex, and selected generic products to Southeast Asian markets, leveraging its local regulatory, commercial, and distribution capabilities
Focus areas: Niche & Complex Generics | Selected Generic Products | Southeast Asian Markets
Contact Us
At Exela BioScience, we value strong partnerships and long-term collaboration.
Whether you are seeking a regional partner to license and commercialize your products in Southeast Asia, explore out-licensing opportunities for selected assets, or establish a distribution partnership, we welcome the opportunity to discuss how we can create long-term value together.
If you are interested in discussing licensing or broader business development opportunities with Exela BioScience, we welcome the opportunity to connect.
Exela BioScience Pte. Ltd.
Address: 470 North Bridge Road, #05-12 Bugis Cube, Singapore (188735).
Email: